Kowloon, Hong Kong, China The standard case for the fund is to invest in rounds with 4 partakers. Despite the Green Tomato, startups are often financed by ShenZhen GTJA Investment Group, Shanghai Fosun Pharmaceutical (Group) Co.,Ltd, Joyful Ascent. The meaningful sponsors for the fund in investment in the same round are ShenZhen GTJA Investment Group, Shanghai Fosun Pharmaceutical (Group) Co.,Ltd, New China Capital Management. In the next rounds fund is usually obtained by New China Capital Management, Loyal Valley Capital, CICC.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Shanghai Henlius. Among the most successful fund investment fields, there are Health Care, Medical.
The average startup value when the investment from Green Tomato is more than 1 billion dollars. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2017.
Related Funds
| Fund Name | Location |
| American Securities | New York, New York, United States |
| Hokuetsu Bank | Japan, Nagaoka, Niigata Prefecture |
| Integrity Partners | Alamo, California, United States |
| Isal Amlat Investments | Israel, Tel Aviv, Tel Aviv District |
| Jaguar Biotech | - |
| Kernel Labs | Seattle, United States, Washington |
| kyu Collective | New York, New York, United States |
| Round13 Capital | Canada, Ontario, Toronto |
| Yuantong Jijin | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shanghai Henlius Biotech | $190M | 22 Dec 2017 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shanghai Henlius Biotech | $190M | 22 Dec 2017 | Shanghai, China |
